BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16890860)

  • 21. [Peripheral arterial disease: what management practices for general practitioners?].
    Priollet P; Mourad JJ; Cacoub P; Lévesque H; Luizy F; Benelbaz J; Herrmann MA; Guerillot M; Blacher J
    J Mal Vasc; 2004 Dec; 29(5):249-56. PubMed ID: 15738836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey.
    Yusuf S; Islam S; Chow CK; Rangarajan S; Dagenais G; Diaz R; Gupta R; Kelishadi R; Iqbal R; Avezum A; Kruger A; Kutty R; Lanas F; Lisheng L; Wei L; Lopez-Jaramillo P; Oguz A; Rahman O; Swidan H; Yusoff K; Zatonski W; Rosengren A; Teo KK;
    Lancet; 2011 Oct; 378(9798):1231-43. PubMed ID: 21872920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk Factors for Suboptimal Utilization of Statins and Antiplatelet Therapy in Patients Undergoing Revascularization for Symptomatic Peripheral Arterial Disease.
    Meltzer AJ; Sedrakyan A; Connolly PH; Ellozy S; Schneider DB;
    Ann Vasc Surg; 2018 Jan; 46():234-240. PubMed ID: 28602895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of ankle-brachial index and dobutamine stress echocardiography for cardiovascular morbidity and all-cause mortality in patients with peripheral arterial disease.
    Thatipelli MR; Pellikka PA; McBane RD; Rooke TW; Rosales GA; Hodge D; Herges RM; Wysokinski WE
    J Vasc Surg; 2007 Jul; 46(1):62-70; discussion 70. PubMed ID: 17583463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence, recognition and treatment of cardiovascular risk factors in outpatients with atherothrombosis in Israel.
    Barski L; Porath A; Novack V; Jotkowitz A
    Isr Med Assoc J; 2007 May; 9(5):376-9. PubMed ID: 17591377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ACE up the sleeve - are vascular patients medically optimized?
    Coveney AP; O'Brien GC; Fulton GJ
    Vasc Health Risk Manag; 2011 Jan; 7():15-21. PubMed ID: 21339909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factor profiles and use of cardiovascular drug prevention in women and men with peripheral arterial disease.
    Sigvant B; Wiberg-Hedman K; Bergqvist D; Rolandsson O; Wahlberg E
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):39-46. PubMed ID: 19237996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factor profile, management and prognosis of patients with peripheral arterial disease with or without coronary artery disease: results of the prospective German REACH registry cohort.
    Zeymer U; Parhofer KG; Pittrow D; Binz C; Schwertfeger M; Limbourg T; Röther J
    Clin Res Cardiol; 2009 Apr; 98(4):249-56. PubMed ID: 19221687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral arterial disease: a review of disease awareness and management.
    Watson K; Watson BD; Pater KS
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):365-79. PubMed ID: 17296541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attainment of Guideline-Directed Medical Treatment in Stable Ischemic Heart Disease Patients With and Without Chronic Kidney Disease.
    Koutroumpakis E; Gosmanova EO; Stahura H; Jou S; Alreshq R; Ata A; Sidhu MS; Philbin E; Boden WE; Lyubarova R
    Cardiovasc Drugs Ther; 2019 Aug; 33(4):443-451. PubMed ID: 31123935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
    Høgh AL
    Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.
    Bianchi C; Montalvo V; Ou HW; Bishop V; Abou-Zamzam AM
    Ann Vasc Surg; 2007 Mar; 21(2):163-6. PubMed ID: 17349357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes in the prescription of cardiovascular prevention drugs in France between 1995 and 2003: factors influencing the gap between evidence base medicine and clinical practice].
    Philippe F; Cambou JP; Danchin N; Thomas D
    Ann Cardiol Angeiol (Paris); 2005 Dec; 54 Suppl 1():S30-6. PubMed ID: 16411649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The best of vascular medicine in 2006].
    Mounier-Vehier C; Stephan D; Aboyans V; Beregi JP; Lacroix P; Léger P; Long A; Sevestre MA;
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():47-55. PubMed ID: 17405565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease.
    ; Anand S; Yusuf S; Xie C; Pogue J; Eikelboom J; Budaj A; Sussex B; Liu L; Guzman R; Cina C; Crowell R; Keltai M; Gosselin G
    N Engl J Med; 2007 Jul; 357(3):217-27. PubMed ID: 17634457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
    Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
    Tran H; Anand SS
    JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug therapies in the secondary prevention of cardiovascular diseases: Successes, shortcomings and future directions.
    Lonn E; Grewal J
    Curr Vasc Pharmacol; 2006 Jul; 4(3):253-68. PubMed ID: 16842143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suboptimal use of statin therapy in elderly patients with atherosclerosis: a population-based study.
    Al-Omran M; Mamdani MM; Lindsay TF; Melo M; Juurlink DN; Verma S;
    J Vasc Surg; 2008 Sep; 48(3):607-12. PubMed ID: 18585886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does pharmacologic treatment in patients with established coronary artery disease and diabetes fulfil guideline recommended targets? A report from the EUROASPIRE III cross-sectional study.
    Gyberg V; Kotseva K; Dallongeville J; Backer GD; Mellbin L; Rydén L; Wood D; Bacquer DD;
    Eur J Prev Cardiol; 2015 Jun; 22(6):753-61. PubMed ID: 24691153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.